Anakinra (brand name Kineret) is a drug used to treat rheumatoid arthritis. It is an
interleukin 1 (IL1) receptor antagonist. It is produced by Swedish Orphan ...
Ask your healthcare provider if you are not sure; Anakinra or any of the
ingredients in Kineret. See the end of the patient leaflet for a complete list of
Kineret (anakinra) is a recombinant, nonglycosylated form of the human
interleukin-1 receptor antagonist (IL-1Ra). Kineret differs from native human IL-
1Ra in ...
Dec 15, 2014 ... anakinra (Kineret) is an arthritis drug prescribed to treat rheumatoid arthritis over
18 years of age. Side effects, drug interactions, storage and ...
Aug 17, 2016 ... The difference between anakinra and the native human IL-1Ra is that anakinra
has an extra methionine residue at the amino terminus.
(anakinra) is a recombinant, nonglycosylated form of the human interleukin-1 ...
anakinra in a solution (pH 6.5) containing sodium citrate (1.29 mg), sodium ...
positive for anti-anakinra binding antibodies at one or more time points using a
biosensor assay. Of the 1615 patients with available data at Week 12 or later, ...
Jul 18, 2016 ... Kineret (anakinra) is used for treating rheumatoid arthritis and neonatal-onset
multisystem inflammatory disease.
Medscape - Indication-specific dosing for Kineret (anakinra), frequency-based
adverse effects, comprehensive interactions, contraindications, pregnancy ...
Jan 21, 2009 ... Anakinra for rheumatoid arthritis. Mertens M(1), Singh JA. Author information: (1)
University of Minnesota, 596 Grand Ave., Apt 1, Saint Paul, ...